U2AF1 and myeloid neoplasm: While the observation that U2AF1S34F and U2AF1Q157P are the most frequent U2AF1 MT in myeloid neoplasms is not new [5, 23–25], our study is the first to demonstrate their unique co-mutational spectrum and differential prognostic effect.